Nurix Therapeutics, Inc. (NRIX)

NASDAQ: NRIX · Real-Time Price · USD

9.38

+0.30 (3.30%)

Oct 3, 2025, 4:00 PM EDT - Market closed

Nurix Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Oct '25 Oct 3, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	2018 - 2019
Market Capitalization	717	1,566	302	584	1,286	1,656	Upgrade
Market Cap Growth	-55.00%	419.13%	-48.35%	-54.57%	-22.36%	-	Upgrade
Enterprise Value	283	1,136	41	184	942	1,302	Upgrade
Last Close Price	9.38	22.11	6.22	12.39	28.82	42.62	Upgrade
PS Ratio	8.45	28.71	3.92	15.12	43.22	92.93	Upgrade
PB Ratio	1.60	2.97	1.51	1.92	3.76	5.71	Upgrade
P/TBV Ratio	1.60	2.97	1.51	1.92	3.76	5.71	Upgrade
EV/Sales Ratio	3.20	20.82	0.53	4.76	31.66	73.05	Upgrade
Debt / Equity Ratio	0.12	0.05	0.15	0.04	0.04	-	Upgrade
Asset Turnover	0.16	0.11	0.20	0.09	0.07	0.08	Upgrade
Quick Ratio	6.70	6.38	3.32	4.39	4.57	6.58	Upgrade
Current Ratio	6.82	6.46	3.40	4.51	4.70	6.70	Upgrade
Return on Equity (ROE)	-50.67%	-53.22%	-57.10%	-55.84%	-37.05%	-30.80%	Upgrade
Return on Assets (ROA)	-26.13%	-25.98%	-25.10%	-25.72%	-16.88%	-18.45%	Upgrade
Return on Capital (ROIC)	-32.04%	-33.86%	-35.45%	-34.25%	-22.82%	-28.93%	Upgrade
Earnings Yield	-28.91%	-12.36%	-47.71%	-30.88%	-9.12%	-2.61%	Upgrade
FCF Yield	-31.49%	-11.61%	-29.75%	-29.45%	-7.00%	-0.28%	Upgrade
Buyback Yield / Dilution	-40.74%	-23.52%	-11.79%	-13.32%	-173.68%	-376.03%	Upgrade

Updated Jul 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q